Experimental CAR T-Cell therapy for rare lymphoma shows promise but trial halted early
Disease control
Terminated
This study tested a new treatment called AUTO4 for people with a rare type of T-cell lymphoma that had returned or stopped responding to standard therapy. AUTO4 is made from a patient's own immune cells, which are reprogrammed to find and attack cancer cells. The trial was stoppe…
Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated May 17, 2026 05:33 UTC